wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q56896966
Q56896966
Item
http://www.wikidata.org/entity/Q56896966
Q56896966
about
Q56896966
Item
http://www.wikidata.org/entity/Q56896966
description
im April 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2014
@uk
type
Item
P1433
Q56896966-27457771-6DC9-40B7-BC89-CFA0D5FA58D7
P2093
Q56896966-524C0670-9F35-4EB8-A06D-82E9EF2A0A36
Q56896966-A54A5A14-8C1A-4F72-ABF6-FA94F7725D07
P2860
Q56896966-0168ACAA-47B2-46F2-808A-AB4D6F19E9E5
Q56896966-0BD580BD-A158-44AD-B31C-C76EB20AA304
Q56896966-22C35F32-079D-42AE-9EBE-C89A99D6167F
Q56896966-2C3C7D2C-707E-44F9-AF9F-BE9791558844
Q56896966-365D7780-096C-497F-BA57-7E8E4345394F
Q56896966-3BE806B9-1720-4465-BDF1-402868FFD924
Q56896966-3C44A43F-43F3-4A89-9F1A-ED47ABB56DE1
Q56896966-47952D2F-30DE-474C-8B11-BBEE9FF7B1E7
Q56896966-4EFAD67D-252B-4BE3-AFC8-A7D089A29AD4
Q56896966-5E1C489D-0CA5-43A1-8334-5E4B9AD6D403
Show more
P304
Q56896966-AE6959C4-FAB7-4A65-93EF-687C7CDE76B6
P31
Q56896966-E6E4A5AF-B56C-4868-A703-7DDBB6F50919
P356
Q56896966-E07B4BC6-4F59-436E-82A5-FAEDC9BD3082
P433
Q56896966-82357F45-E827-4BD7-8593-008391FC584B
P478
Q56896966-AECF8F9D-D8B8-4568-994D-418D148EC947
P577
Q56896966-C54877DD-D109-42BA-B3E2-14A404AAF1EF
P698
Q56896966-DDD223A0-AB0A-487C-95F3-7575EAEBA345
P356
S00108-013-3414-5
P1433
Der Internist
P2093
M Bitzer
http://www.w3.org/2001/XMLSchema#string
N P Malek
http://www.w3.org/2001/XMLSchema#string
P2860
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
CD28 and CTLA-4 coreceptor expression and signal transduction
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.
Germline met mutations in mice reveal mutation- and background-associated differences in tumor profiles.
Targeting the EGFR signaling pathway in cancer therapy.
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp
Show more
P304
359-66
http://www.w3.org/2001/XMLSchema#string
P31
scholarly article
P356
10.1007/S00108-013-3414-5
http://www.w3.org/2001/XMLSchema#string
P433
4
http://www.w3.org/2001/XMLSchema#string
P478
55
http://www.w3.org/2001/XMLSchema#string
P577
2014-04-01T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P698
24619098
http://www.w3.org/2001/XMLSchema#string